Andrew Khoo

Andrew Khoo is a seasoned entrepreneur and executive with a strong background in the automotive and biopharmaceutical sectors. As Co-Founder and Group CEO of Moladin since 2021, Andrew has led the development of a leading omnichannel used car dealership in Indonesia, harnessing technology to enhance customer experiences and foster a network of over 15,000 agents and dealers. Prior to this, Andrew co-founded Tessa Therapeutics Ltd in 2012, serving as CEO until 2020, where significant achievements included growing the team to over 200, initiating the world's largest T cell therapy Phase 3 cancer trial, and securing over USD 250 million in funding. Additionally, Andrew was a Founding Investor and Director at Enleofen Bio from 2017 to 2019, playing a key role in a major licensing deal valued at up to EUR 3 billion. Andrew holds a Bachelor of Science degree in Chemistry from Stanford University.